Westwood Holdings Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-116,111
Closed -$6.67M 503
2023
Q1
$6.67M Buy
116,111
+7,906
+7% +$445K 0.06% 228
2022
Q4
$6.07M Sell
108,205
-122,739
-53% -$6.25M 0.05% 233
2022
Q3
$9.78M Buy
230,944
+38,930
+20% +$1.99M 0.12% 180
2022
Q2
$10.4M Buy
192,014
+56,285
+41% +$3.38M 0.11% 193
2022
Q1
$8.72M Buy
135,729
+31,437
+30% +$2.07M 0.08% 203
2021
Q4
$6.99M Sell
104,292
-48,171
-32% -$3.26M 0.06% 218
2021
Q3
$10.4M Buy
152,463
+30,305
+25% +$2.14M 0.11% 190
2021
Q2
$8.34M Sell
122,158
-9,596
-7% -$679K 0.08% 200
2021
Q1
$9.1M Buy
131,754
+31,344
+31% +$2.12M 0.09% 215
2020
Q4
$6.52M Sell
100,410
-60,207
-37% -$3.24M 0.08% 217
2020
Q3
$7.58M Buy
160,617
+21,608
+16% +$1.03M 0.1% 213
2020
Q2
$6.53M Sell
139,009
-474
-0.3% -$23.3K 0.09% 226
2020
Q1
$6.23M Sell
139,483
-14,179
-9% -$744K 0.09% 219
2019
Q4
$8.96M Buy
153,662
+9,487
+7% +$565K 0.1% 222
2019
Q3
$8.66M Buy
+144,175
New +$8.59M 0.1% 216
2018
Q4
Sell
-14,935
Closed -$984K 408
2018
Q3
$984K Sell
14,935
-4,240
-22% -$263K 0.01% 311
2018
Q2
$1.24M Sell
19,175
-562,332
-97% -$34.8M 0.01% 312
2018
Q1
$32.2M Buy
+581,507
New +$30.5M 0.26% 116
2017
Q2
Sell
-169,229
Closed -$7.13M 516
2017
Q1
$7.13M Buy
169,229
+9,715
+6% +$415K 0.06% 214
2016
Q4
$6.84M Sell
159,514
-900,856
-85% -$36.6M 0.06% 226
2016
Q3
$43.8M Sell
1,060,370
-89,576
-8% -$3.75M 0.37% 103
2016
Q2
$45.9M Sell
1,149,946
-151,986
-12% -$5.47M 0.41% 92
2016
Q1
$43.8M Buy
1,301,932
+174,094
+15% +$5.42M 0.38% 95
2015
Q4
$38.2M Sell
1,127,838
-84,612
-7% -$2.64M 0.33% 108
2015
Q3
$36.1M Sell
1,212,450
-488,817
-29% -$15.3M 0.31% 115
2015
Q2
$46.8M Sell
1,701,267
-132,880
-7% -$3.54M 0.35% 113
2015
Q1
$46.2M Sell
1,834,147
-24,829
-1% -$587K 0.35% 114
2014
Q4
$41.2M Sell
1,858,976
-12,957
-0.7% -$263K 0.32% 118
2014
Q3
$38M Buy
+1,871,933
New +$37.3M 0.3% 119

Other funds holding IART

Westwood Holdings Group's IART Position: Q2 2023 in Review

Westwood Holdings Group sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 116,111 shares — an estimated $6.67M sold.

Westwood Holdings Group first reported a position in IART in Q3 2014 and held it in 29 quarters. The position peaked at $46.8M in Q2 2015. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Westwood Holdings Group reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 116,111 Integra LifeSciences shares in Q2 2023, an estimated $6.67M.
  • Westwood Holdings Group first reported a position in Integra LifeSciences in Q3 2014 and held it in 29 quarters.
  • Westwood Holdings Group's Integra LifeSciences position peaked at $46.8M in Q2 2015.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Westwood Holdings Group's 13F filing for Q2 2023, filed 11 Aug 2023.